Why does quantifying receptor clusters per beam area matter for target validation?

Quantifying clusters per beam area provides a normalized, quantitative measure of receptor aggregation state, enabling objective comparison between basal and ligand-stimulated conditions to assess target engagement and functional consequences of drug binding.

How does isolating the EGF-stimulated variable support discovery pipeline decision-making?

By stimulating cells with EGF ligand and comparing to unstimulated controls, the protocol isolates the effect of a specific activator on receptor clustering, enabling clear attribution of observed changes to target pathway modulation in early target validation.

What quantitative dependent variable measurement enables assessment of receptor aggregation?

The dependent variable is clusters per beam area, calculated from the peak value of the normalized autocorrelation function’s point spread function profile, providing a direct readout of receptor density and clustering efficiency on the cell surface.

Why do replication requirements matter for cross-functional collaboration in target validation?

Collecting multiple replicates ensures statistical reliability and reproducibility of clustering measurements, which is essential for generating consistent data that inform go/no-go decisions across discovery biology, assay development, and preclinical teams.

What statistical analysis capability is required before implementing this method in a discovery workflow?

The ability to normalize autocorrelation data, calculate peak values from point spread function profiles, and derive clusters per beam area using the formula (1/peak − 1) is required to ensure accurate, comparable quantification of receptor aggregation states across experimental conditions.

Confocale microscopie onthult cel oppervlakte Receptor aggregatie via afbeelding correlatie spectroscopie

6.8K weergaven

Geciteerd door 5

06:51 min

2 augustus 2018

10.3791/57164-v

2 augustus 2018

6.8K weergaven

Adam C. Parslow¹^,² , Andrew H.A. Clayton³ , Peter Lock⁴ , Andrew M. Scott¹^,²^,⁵^,⁶^,⁷

¹Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, ²School of Cancer Medicine, La Trobe University, ³Centre for Micro-Photonics, Faculty of Science, Engineering and Technology, Swinburne University of Technology, ⁴LIMS Bioimaging Facility, La Trobe Institute for Molecular Science, La Trobe University, ⁵Department of Medical Oncology, Olivia Newton-John Cancer and Wellnes Centre, Austin Health, ⁶Department of Medicine, University of Melbourne, ⁷Department of Molecular Imaging and Therapy, Austin Health

Antilichamen die zich aan target receptoren van het celoppervlak binden kunnen verlenen bevleesdheid en clustering wijzigingen. Deze dynamische veranderingen hebben gevolgen voor het karakteriseren van Geneesmiddelenontwikkeling in de doelcellen. Dit protocol maakt gebruik van de confocal microscopie en afbeelding correlatie spectroscopie via ImageJ/FIJI te kwantificeren van de omvang van de receptor clustering op het celoppervlak.